Zhang XT - Search Results

1

[Evaluation of efficacy and safety of ZD1839 as monotherapy in Chinese patients with advanced non-small cell lung cancer].

Wang MZ, Li LY, Wang SL, Zhang XT, Zhong W, Zhang L, Li JR. Wang MZ, et al. Among authors: zhang l, zhang xt. Zhonghua Nei Ke Za Zhi. 2008 Apr;47(4):291-5. Zhonghua Nei Ke Za Zhi. 2008. PMID: 18843952 Chinese.

2

[Retrospective analysis of 27 cases of disseminated tuberculosis].

Zhang XT, Li LY, Zhang L, Zhu YJ, Cui QC. Zhang XT, et al. Among authors: zhang l. Zhonghua Nei Ke Za Zhi. 2004 Jan;43(1):41-4. Zhonghua Nei Ke Za Zhi. 2004. PMID: 14990021 Chinese.

3

[Gefitinib for advanced bronchioloalveolar carcinoma].

Zhang XT, Wang SL, Li LY. Zhang XT, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Jun;26(3):340-3. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004. PMID: 15266843 Chinese.

4

Evaluation of safety and efficacy of gefitinib ('iressa', zd1839) as monotherapy in a series of Chinese patients with advanced non-small-cell lung cancer: experience from a compassionate-use programme.

Mu XL, Li LY, Zhang XT, Wang SL, Wang MZ. Mu XL, et al. Among authors: zhang xt. BMC Cancer. 2004 Aug 19;4:51. doi: 10.1186/1471-2407-4-51. BMC Cancer. 2004. PMID: 15318946 Free PMC article. Clinical Trial.

5

[Treatment of non-small cell lung cancer with gefitinib].

Zhang XT, Li LY, Wang SL, Mu XL, Wang MZ. Zhang XT, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2005 Mar;28(3):180-3. Zhonghua Jie He He Hu Xi Za Zhi. 2005. PMID: 15854414 Chinese.

6

Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.

Mu XL, Li LY, Zhang XT, Wang MZ, Feng RE, Cui QC, Zhou HS, Guo BQ. Mu XL, et al. Among authors: zhang xt. Clin Cancer Res. 2005 Jun 15;11(12):4289-94. doi: 10.1158/1078-0432.CCR-04-2506. Clin Cancer Res. 2005. PMID: 15958609

7

Improvements in quality of life and disease-related symptoms in patients with advanced non-small cell lung cancer treated with gefitinib.

Zhang XT, Li LY, Wang SL, Mu XL, Wang MZ, Song W. Zhang XT, et al. Chin Med J (Engl). 2005 Oct 5;118(19):1661-4. Chin Med J (Engl). 2005. PMID: 16232354 No abstract available.

8

Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer.

Wang MZ, Li LY, Wang SL, Zhang XT, Zhong W, Zhang L. Wang MZ, et al. Among authors: zhang l, zhang xt. Chin Med J (Engl). 2006 Jan 5;119(1):63-8. Chin Med J (Engl). 2006. PMID: 16454984 No abstract available.

9

Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China.

Wu YL, Zhong WZ, Li LY, Zhang XT, Zhang L, Zhou CC, Liu W, Jiang B, Mu XL, Lin JY, Zhou Q, Xu CR, Wang Z, Zhang GC, Mok T. Wu YL, et al. Among authors: zhang l, zhang xt, zhang gc. J Thorac Oncol. 2007 May;2(5):430-9. doi: 10.1097/01.JTO.0000268677.87496.4c. J Thorac Oncol. 2007. PMID: 17473659 Free article.

10

[Efficacy and safety of gefitinib monotherapy for Chinese elderly patients with advanced non-small cell lung cancer].

Zhang L, Wang SL, Zhang XT, Li LY, Wang MZ. Zhang L, et al. Among authors: zhang xt. Zhonghua Nei Ke Za Zhi. 2007 May;46(5):392-5. Zhonghua Nei Ke Za Zhi. 2007. PMID: 17637309 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

577 results

Search Page

Filters